Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Almost at $4 before news
View:
Post by 2019champs on Nov 16, 2021 5:33pm

Almost at $4 before news

Couple of months ago i thought $2 before news would be a good spot to be in. Fast forward, we are at $4 before news. I just can't see a company taking this long to come out and say the data wasn't good or inconclusive. It just doesn't make sense. No raise at an all time high either? Folks, this is big. If data wasn't good you would do a raise like AGN or APLI did ASAP. Not the case here. That has me thinking either A) Company has stellar data and thinks they can raise much higher or B) the funding is coming from elsewhere for a potential phase 3. The savy investors know this and are buying. The clueless folks who think the delay is bad news are selling lol, and then you still have delusional canadian investors who think aurora cannabis is a great investment. We are in terrific shape here folks.
Comment by wethenorthh on Nov 16, 2021 10:05pm
Totally agree with your take. The biggest news in the companys history (up until now of course) and it's taking this long? Must be something great in the works. Always thought we needed to get past $2 before news but we're at $4!!! Still severely underrated like Riverfolk has stated.  Soon enough people will realize and pay greatly for shares... 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities